A Cooperative Randomized Study on Tegafur plus Mitomycin C versus Combined Tegafur and Uracil plus Mitomycin C in the Treatment of Advanced Gastric Cancer
β Scribed by Kurihara, Minoru ;Izumi, Tuguhiko ;Yoshida, Shigeaki ;Ohkubo, Toshiharu ;Suga, Shoji ;Kiyohashi, Atsushi ;Yaosaka, Tohru ;Takahashi, Hiromu ;Ito, Tetsuo ;Sasai, Tadashi ;Akiya, Toshikazu ;Akazawa, Shugo ;Betsuyaku, Takashi ;Taguchi, Susumu
- Book ID
- 108579335
- Publisher
- Wiley (Blackwell Publishing)
- Year
- 1991
- Tongue
- English
- Weight
- 414 KB
- Volume
- 82
- Category
- Article
- ISSN
- 0910-5050
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a phase 111 randomized trial of adjuvant chemotherapy for gastric cancer, interinstitutional differences were analyzed. A trial of three regimens: mitomycin C, 5-fluorouracil(5-FU) and CA (MFC) + continuous oral 5-FU (Group C); MFC + continuous oral UFT(tegafur and uracil) (Group B); and MF + UFT
## Background: Both the biochemical modulation and the continuous administration of 5-fluorouracil (5-fu) have achieved promising results in patients with gastric carcinoma. conversely, several studies on gastric carcinoma have demonstrated that the combination of etoposide (vp-16), leucovorin (lv)